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Table I. Demographic and clinical data
Demographic and clinical data of all study patients
Radial group
(n=130)
Femoral group
(n=130) P value
Age 66.88.9 66.710.2 0.856
Male (%) 60.8 65.4 0.441
Hypertension (%) 77.7 88.5 0.021
Hyperlipidaemia
(%)
56.2 47.7 0.172
Diabetes mellitus
(%)
36.2 36.9 0.898
Obesity (%) 14.6 34.6 0.0003
Smoker (%) 28.5 26.9 0.889
Peripheral artery
disease (%)
13.9 13.8 1.000
Coronary artery
disease (%)
24.6 24.6 0.776
Positive family
history (%)
6.9 9.2 0.495
Dialysis (%) 6.2 3.1 0.237
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Background: Carotid artery stenting (CAS) has become an alternative for carotid
endarterectomy in the treatment of carotid arteries atherosclerosis due to low
procedural injury and comparable procedural risk. Patients with coronary artery
disease have a higher risk of surgical treatment than in CAS procedure. The impact
of coronary artery disease (CAD) during long term follow-up (FU) needs reconsi-
dering due to the intensiﬁcation of aggressive pharmacotherapy in CAD during
recent years.
Methods: Data of 130 symptomatic and asymptomatic patients undergoing CAS
from January 2002 to December 2010 were divided in two groups: with and without
CAD. All CAS procedures were performed with application of cerebral protection
devices. Major adverse cardio and cerebrovascular events (MACCE) during follow-
up were deﬁned as combination of death (cardiac and non-cardiac), myocardial
infarction and stroke/TIA. Long-term outcomes of patients were stratiﬁed based on
history of CAD.
Results: The mean age of patients was 669 years, majority of patients were male
(80.2%). Long-term follow-up data were available in 86.2% of patients. During mean
follow-up of 71.931.7 months all-cause mortality rate was 19.6%. The rates of
myocardial infarction, stroke/TIA, and MACCE - were 14.3%, 11.6%, and 37.5%
respectively. The frequency of MACCE during long-term follow-up was higher in
patients with CAD vs without CAD (40.8% vs 6.7%,p ¼ 0.01) and the mortality rate
in the two groups was (22.2% vs 0%, p ¼ 0.07) respectively.
Conclusions: Patients with symptomatic or asymptomatic carotid stenosis are a high-
risk individuals with many coexisting diseases. The presence of CAD increases the
risk of MACCE in such patients during long-term follow-up.
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Background: Current guidelines recommend to perform Carotid Artery Stenting
(CAS) procedures with embolic protection devices (EPDs). Among these, prox-
imal EPDs such as the endovascular clamping (MO.MA. Medtronic INC) have the
advantage of providing embolic protection during all phases of the intervention.
However, endovascular clamping of the common carotid artery can expose theB154 JACC Vol 62/18/Suppl B j October 27–November 1, 2ipsilateral hemisphere to hypoperfusion and produce transient neurological
symptoms (clamping intolerance). The aim of the present study was to identify
the predictors of developing carotid clamping intolerance during CAS with
MO.MA.
Methods: From March 2010 to March 2012, 605 consecutive patients underwent
CAS using MO.MA. as EPD at our institution. Clamping intolerance was deﬁned as
any transient neurological deﬁcit observed during occlusion time, but showing
a complete recovery within 20 min after restoring antegrade ﬂow. To identify
predictors of clamping intolerance a logistic regression model was developed
including all patients' clinical characteristics, the presence of ICA stenosis >90%, the
presence of ipsilateral ECA stenosis, the presence of contralateral ICA stenosis (75-
99%) and occlusion, clamping pressure 40 mmHg, and arterial pressure delta >50
mmHg.
Results: 184 patients (30.4%) developed clamping intolerance during the CAS
procedure. Compared to patients without clamping intolerance, those who experienced
intolerance showed a lower clamping pressure (42.312.7 vs 61.9 5.4 mmHg,
p<0.001). ROC curve analysis showed that clamping pressure was the most consistent
predictor with a c-statistic of 0.85 (95% CI 0.82-0.88) and best cut-off being 40
mmHg (sensitivity 68.5%, speciﬁcity 93.3%). Logistic regression analysis showed
that the most powerful independent predictor of clamping intolerance was a clamping
pressure 40 mmHg (HR¼34.2, 95% CI 19.7-59.6) and that the most powerful
clinical predictor of such clamping pressure was the presence of contralateral ICA
occlusion (HR¼3.1, 95% CI 1.5-6.2).
Conclusions: Clamping intolerance may occur in up to a third of the patients
undergoing CAS with endovascular clamping. This event is more common in those
patients presenting a clamping pressure 40 mmHg.
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Background: It is not known whether racial or ethnic disparities observed with other
revascularization procedures are also seen with carotid artery stenting (CAS) and
endarterectomy (CEA).
Methods: We compared the utilization of CAS and CEA across racial/ethnic groups
within the CARE Registry between May 2005 - Dec 2012. Differences in clinical
characteristics, procedural variables, and major adverse cardiac and cerebrovascular
events (MACCE) were studied.
Results: Between 2005 and 2012, of the 13,129 patients who underwent CAS,
majority were non-Hispanic Caucasians (NHC 89.3%), followed by African Ameri-
cans (AA 4.4%), Hispanics (H 4.3%), and other groups (OG 2.0%). A similar
distribution was observed among the 10,953 patients undergoing CEA (NHC 92.6%,
AA 3.5%, H 2.8%, and OG 1.1%). During this time period, a trend toward propor-
tionate increase in CAS utilization was observed in NHC and OG whereas the
opposite was observed among H and AA (Fig 1). This trend persisted even when
hospitals performing both CAS and CEA were exclusively analyzed. Adherence to
anti-platelet and statin therapy was signiﬁcantly lower among AA post-CEA. In-
hospital MACCE remained comparable across groups post-CAS whereas post CEA,
there was a signiﬁcant decline in MACCE among NHC only (p¼0.04). At 30 days, the
incidence of death (2.2%), stroke (7.2%), and MACCE (8.8%) was higher among AA
post-CEA (p<0.05).013 j TCT Abstracts/POSTER/Carotid and Neurovascular Intervention
www.jacctctabstracts2013.com TUESDAY, OCTOBER 29, 2013, 3:30 PM–5:30 PMConclusions: During the study period, utilization of CAS & CEA was highest
in NHC. There was a trend toward increased CAS utilization over time among
NHC and OG, and a trend toward increased CEA utilization among H and
AA.TCT-508
Transcatheter Treatment of Patients after Extensive Ischemic Stroke
Ivan V. Maksimovich1
1Clinic of Cardiovascular Diseases named after Most Holy John Tobolsky, Moscow,
Russian Federation
Background: The research investigates the possibility of reducing cognitive disorders
and restoring activities of daily living in patients after extensive ischemic stroke using
transcatheter cerebral revascularization.
Methods: 92 patients aged 32-72 having undergone extensive ischemic stroke
spreading to different parts of the brain were examined. The patients underwent:
Index Bartels (IB), CT, brain MRI, scintigraphy (SG), rheoencephalography (REG),
MUGA. 68 patients underwent transcatheter treatment - Test Group. 24 patients
underwent conservative treatment - Control Group. High-energy pulsed laser
systems were used for revascularization of the major intracranial arteries; low-energy
continuous laser systems were used for revascularization of the distal intracranial
branches.
Results: Test Group. 66 (95.59%) patients had a good immediate angiographic
outcome manifested in the restoration of lumen and patency of the affected vessels
as well as in collateral revascularization. 12-24 months later the following positive
dynamics was observed: good clinical outcome (almost complete intellectual abilities
and motor functions restoration - IB90-100) - 14 (20.59%) patients; satisfactory
clinical outcome (incomplete intellectual abilities and motor functions restoration -
IB75-85) - 30 (44.12%) patients; relatively satisfactory clinical outcome (partial
intellectual abilities and motor functions restoration - IB60-70) - 24 (35.29%)
patients; relatively positive clinical outcome (absence of negative dynamics with
insigniﬁcant restoration of motor functions – IB<60) was not obtained in any case.
Control Group. 12-24 months later the following dynamics was observed: good
clinical outcome was not obtained in any case; satisfactory clinical outcome was not
obtained in any case; relatively satisfactory clinical outcome - 4 (16.67%) cases;
relatively positive clinical outcome - 20 (83.33%) cases.
Conclusions: In the treatment of extensive ischemic stroke effects, transcatheter
cerebral revascularization is a more effective method than the therapeutic one. It can
signiﬁcantly reduce the level of cognitive impairment and return patients to active
daily life.P
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mercogliano, ItalyJACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT AbstrBackground: At present few data exist on the impact on outcome of the use
of different carotid stent types during neuroprotected carotid artery stenting
(CAS). Aim of this study was to evaluate the outcomes associated with neu-
roprotected CAS in selected high volume centers according to different carotid
stent design.
Methods: From January 2007 to December 2007, 1611 patients underwent neuro-
protected CAS in eight European Centers (ERCAS registry). An independent
clinical events committee adjudicated the events. All types of commercially avail-
able carotid stents were used (closed, open and hybrid cell designed). Open cell
designed stent were classiﬁed according to cell free area (< 7.5 mm2 or >7.5
mm2).
Results: 728 closed-cell, 456 hybrid-cell, 234 <7.5 mm2 open-cell, and 193 >7.5
mm2 open-cell stents were implanted. At 30-days 18 strokes occurred (1.12%; 7
(0.96%) in those treated with a closed-cell, 2 (0.44%) in those with a hybrid-cell,
3 (1.28%) in those with a <7.5 mm2 open-cell, and 6 (3.10%) in those treated
with a >7.5 mm2 open-cell stent, p¼0.029). Overall 30 days stroke and death rate
was 1.36%, and no statistically signiﬁcant difference was observed among the
groups.
Conclusions: CAS is a reasonable alternative to carotid endarterectomy as it is
associated with excellent outcomes when performed in well-experienced high
volume centers. Data of the present study suggest that the use of open cell
designed stent with free cell area >7.5 mm2 is associated with an increased 30
days stroke risk. However, future randomized trials are needed to conﬁrm this
ﬁnding.TCT-510
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Background: Some descriptions had shown increased risk for neurological compli-
cations in the case of aortic arch anomalies, bovine arch frequency was 10.2%,
technical failure 12% and complications in 20% of patients. The aim is to compare the
frequency of adverse events in type III arch patients with bovine arch patients in
complex aortic arch (CAA) carotid artery stenting.
Methods: 407 carotid angioplasties with stenting were done. The patients were
divided into two groups: CAA (group 1: 114 patients) and control group (group 2:
293 patients). Patients in the CAA were divided into type III arch (group 3: 48
patients) and bovine arch (group 4: 66 patients). The endpoints were the
composite of major cardiovascular adverse events (death, major stroke and
myocardial infarction), major stroke,transitory ischemic attack (TIA) and the
composite of contrast medium nephropathy, haemoglobin dropping more than 2
grs within 24 hours after procedure or complications related to puncture site such
as haematoma, pseudoaneurysm or arterio venous ﬁstula, called "other adverse
events".
Results: The rate of TIA was a little higher in the CAA group 2.63% (p¼0.022),
compared with control, because of the higher rate in the type III group (4.1% p¼
0.003). For the endpoint "other adverse events" there were more events in the CAA
group (12 patients 10.52% p¼ 0.022), but this depends on a signiﬁcantly higher
frequency of events in the type III group (8 patients 16.6% of the type III p¼ 0.001).
At 30 days follow up there were increases in the frequency of major stroke and TIA in
the CAA group (4.3% and 2.63% of group 1, p¼ 0.023 and 0.022). These events were
more frequent in group 3 (type III) 4.16% for both endpoints p¼ 0.108 for major stoke
and 0.038 for TIA.
Conclusions: There were signiﬁcantly more periprocedural adverse events in the
CAA group in the endpoint of "other adverse events" and TIA. In these two cases,
most events were in the type III aortic arch group. The aortic arch type III seems
to be responsible for most adverse events in the carotid stenting of the CAA
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